Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 7/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13120985 | 1.00 | CASP2 (0.57) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL19438356 | 0.91 | CASP2 (0.61) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL20873621 | 0.91 | CASP2 (0.61) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL12891254 | 0.88 | EPHX2 (0.51) | CASP2FAAHSLC6A5EPHX2KDM4E | |
| SCHEMBL25878526 | 0.88 | NOD1 (0.63) | SLC6A5EPHX2NOD1 | |
| SCHEMBL25877865 | 0.88 | NOD1 (0.63) | SLC6A5EPHX2NOD1 | |
| SCHEMBL21563328 | 0.86 | CASP2 (0.59) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL47703 | 0.86 | CASP2 (0.59) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL12666301 | 0.86 | CASP2 (0.59) | CASP2FAAHNAAASLC6A5DNM1 | |
| SCHEMBL20634894 | 0.85 | CASP2 (0.42) | CASP2FAAHNAAASLC6A5DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023139106-A2 | LONG-ACTING GIPR ANTAGONISTS | NOVO NORDISK A/S (DK) | 2023-07-27 | — | — | WO | disclosed |